TY - JOUR
TI - Response to correspondence: Testing for myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in typical MS
AU - Breza, M.
AU - Koutsis, G.
AU - Tzartos, J.S.
AU - Velonakis, G.
AU - Evangelopoulos, M.E.
AU - Tzanetakos, D.
AU - Karagiorgou, K.
AU - Angelopoulou, G.
AU - Kasselimis, D.
AU - Potagas, C.
AU - Anagnostouli, M.
AU - Stefanis, L.
AU - Kilidireas, C.
JO - Multiple Sclerosis and Related Disorders
PY - 2019
VL - 35
TODO - null
SP - 156-157
PB - Elsevier B.V.
SN - 2211-0348
TODO - 10.1016/j.msard.2019.07.018
TODO - biological marker;  complement;  immunoglobulin G;  immunoglobulin G1 antibody;  myelin oligodendrocyte glycoprotein antibody;  protein antibody;  unclassified drug;  immunoglobulin G;  myelin oligodendrocyte glycoprotein, antibody titer;  antigen specificity;  brain damage;  cell assay;  clinical feature;  conus medullaris;  corpus callosum;  demyelinating disease;  disease association;  false positive result;  human;  immunoassay;  Letter;  multiple sclerosis;  nuclear magnetic resonance imaging;  patient care;  phenotype;  prognosis;  demyelinating disease, Demyelinating Diseases;  Humans;  Immunoglobulin G;  Multiple Sclerosis;  Myelin-Oligodendrocyte Glycoprotein
TODO - null
ER -